Viral Hepatitis

Due to the widespread infection of HCV and demand for these enhanced treatments, multiple estimates forecast the global market for HCV treatment will reach $20 billion yearly before the decade's get over.

Hepatitis is a medical condition defined by the inflammation of the liver and characterized by the presence of inflammatory cells in the tissue of the organ. Hepatitis A is an intense irresistible infection of the liver caused by the hepatitis A virus. Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) which affects the liver. It can cause both intense and chronic infections. HCV is spread primarily by blood-to-blood contact connected with intravenous drug use, inadequately cleaned therapeutic gear, and transfusions.

  • Hepatitis A
  • Hepatitis B
  • Hepatitis C
  • Hepatitis D
  • Hepatitis E
  • Epidemiology hepatitis
  • Hepatitis virology and immunology

Related Conference of Viral Hepatitis

October 26-28, 2017

8th Clinical Microbiology Conference

Paris, France
November 29-December 01, 2017

4th World Congress and Expo on Applied Microbiology

Madrid, Spain
July 02-04, 2018

10th International Virology Congress and Expo

Vienna, Austria
February 22-23, 2018

8th Global Summit on Microbiology & Infectious Diseases

Paris, France
June 28-29, 2018

11th Annual Medical Microbiology Summit & Expo

Amsterdam, Netherlands
July 11-12, 2018

2nd International Conference on Microbial Ecology & Eco Systems

Toronto, Ontario, Canada
(10 Plenary Forums 2 days 1 event)
July 11-12, 2018

7th International conference on Environmental Microbiology & Soil Microbiology

Toronto, Ontario, Canada
(10 Plenary Forums 2 days 1 event)
July 16-18, 2018 London, UK

Microbialphysiology 2018

September 10-11, 2018

47th World Congress on Microbiology

London, UK
(9 Plenary forums, 2 days, 1 event)
December 05-06, 2018

8th Annual Congress on Clinical Microbiology

Toronto, Ontario, Canada

Viral Hepatitis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in